These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 2189588)

  • 1. Quality control of BCG vaccine by WHO: a review of factors that may influence vaccine effectiveness and safety.
    Milstien JB; Gibson JJ
    Bull World Health Organ; 1990; 68(1):93-108. PubMed ID: 2189588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. WHO Informal Consultation on standardization and evaluation of BCG vaccines Geneva, Switzerland 22-23 September 2009.
    Ho MM; Southern J; Kang HN; Knezevic I
    Vaccine; 2010 Oct; 28(43):6945-50. PubMed ID: 20692219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [BCG vaccination: characteristics of drugs and causes of vaccinal complications].
    Levi DT; Aksenova VA; Zakirova NR; Aleksandrova NV
    Probl Tuberk; 1999; (4):4-7. PubMed ID: 10479921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Historical review of BCG vaccine in Japan.
    Yamamoto S; Yamamoto T
    Jpn J Infect Dis; 2007 Nov; 60(6):331-6. PubMed ID: 18032829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Adverse events following immunization with BCG vaccine in Poland 1994-2000].
    Szczuka I
    Przegl Epidemiol; 2002; 56(2):205-16. PubMed ID: 12371352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Severe adverse reactions after vaccination with Japanese BCG vaccine: a review].
    Toida I; Nakata S
    Kekkaku; 2007 Nov; 82(11):809-24. PubMed ID: 18078106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Standardized viability test required for preventive, immunomodulator and recombinant BCG vaccine.
    Lugosi L
    Dev Biol Stand; 1992; 77():211-5. PubMed ID: 1426664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Report of clinical testing of BCG vaccine (Strain "1331 Copenhagen") for vaccination of newborns against tuberculosis (author's transl)].
    Nevermann L; Beutnagel H; Schumann K
    Geburtshilfe Frauenheilkd; 1976 Jun; 36(6):481-4. PubMed ID: 780189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Novel vaccines against M. tuberculosis].
    Okada M
    Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Statistical quality control methods in standardization of BCG vaccines.
    Lugosi L
    Dev Biol Stand; 1986; 58 ( Pt A)():213-27. PubMed ID: 3596031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Theoretical and methodological aspects of BCG vaccine from the discovery of Calmette and Guérin to molecular biology. A review.
    Lugosi L
    Tuber Lung Dis; 1992 Oct; 73(5):252-61. PubMed ID: 1493232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Adverse events following BCG vaccination].
    Sagić L
    Med Pregl; 2004; 57 Suppl 1():41-7. PubMed ID: 15686221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of BCG vaccine strain on the immune response and protection against tuberculosis.
    Ritz N; Hanekom WA; Robins-Browne R; Britton WJ; Curtis N
    FEMS Microbiol Rev; 2008 Aug; 32(5):821-41. PubMed ID: 18616602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expanded programme on immunization. Formulation of Pasteur BCG vaccine.
    Wkly Epidemiol Rec; 1990 Mar; 65(13):99. PubMed ID: 2386672
    [No Abstract]   [Full Text] [Related]  

  • 15. [Amendment of tuberculosis prevention law and prospect of tuberculosis control program].
    Ushio M
    Kekkaku; 2005 Jul; 80(7):541-6. PubMed ID: 16167781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significance of the number of viable units in BCG vaccines.
    Nyerges G; Drinóczy M
    Dev Biol Stand; 1986; 58 ( Pt A)():331-6. PubMed ID: 3297870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality control tests for vaccines in leprosy vaccine trial, Avadi.
    Sreevatsa ; Hari M; Gupte MD
    Indian J Lepr; 1998; 70(4):389-95. PubMed ID: 10189588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigations into an outbreak of suppurative lymphadenitis with BCG vaccine SSI(®) in Singapore.
    Soh SB; Han PY; Tam KT; Yung CF; Liew WK; Tan NW; Chong CY; Thoon KC
    Vaccine; 2014 Oct; 32(44):5809-15. PubMed ID: 25173482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Safety of BCG vaccinations--adverse effects following immunization. Part II. Causes of complications. Clinical management].
    Szczuka I
    Przegl Epidemiol; 2002; 56(1):15-28. PubMed ID: 12150058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential productions of lipid virulence factors among BCG vaccine strains and implications on BCG safety.
    Chen JM; Islam ST; Ren H; Liu J
    Vaccine; 2007 Nov; 25(48):8114-22. PubMed ID: 17954004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.